BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)
CUSIP: 088786108
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,984,905
- Total 13F shares
- 6,635,216
- Share change
- +6,635,216
- Total reported value
- $66,751,000
- Price per share
- $10.06
- Number of holders
- 14
- Value change
- +$66,751,000
- Number of buys
- 14
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2019
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q2 2019
As of 30 Jun 2019,
BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,635,216 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Aquilo Capital Management, LLC, VICTORY CAPITAL MANAGEMENT INC, Polar Capital LLP, Laurion Capital Management LP, BlueCrest Capital Management Ltd, Pentwater Capital Management LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q4 2025 Across Filers
Q4 2025 holders
108
Q2 2019 holders
14
Holder diff
-94
| Investor | Q4 2025 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.